Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.In trading on Thursday, shares of Cardiome Pharma Corp ( CRME) entered into oversold territory, hitting an RSI reading of 29.4, after changing hands as low as $8.37 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 38.8. A bullish investor could look at CRME's 29.4 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of CRME shares: Looking at the chart above, CRME's low point in its 52 week range is $7.12 per share, with $11.31 as the 52 week high point — that compares with a last trade of $8.37.
More from Stocks
Coca-Cola Sees Stronger 2019 Operating Income Growth as Q3 Sales Top Forecasts
Coca-Cola says it sees improving operating income for this year, despite stiffer headwinds from a stronger U.S. dollar, as growth of its trademark soft drink, as well as zero-sugar and healthier options, drove solid third-quarter sales growth.
Under Armour Operations Improve but Revenue Growth Lags: Susquehanna Analyst
The firm lowered its price target on the Baltimore sports-apparel producer to $14 a share from $16.
Coke and Pepsi Dump Sugar, Sweeten Earnings Prospects as Consumer Habits Change
Coke joined rival Pepsi in riding a renewed wave of demand for sugar-free and low-calorie soft drinks to firmer-than-expected sales this quarter, confirming the industry's focus on healthier snacks and changing consumer habits.